Supernus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Supernus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Supernus Today - Breaking & Trending Today

Supernus to Participate in the Jefferies Healthcare Conference

ROCKVILLE, Md., May 31, 2023 Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system . | May 31, 2023 ....

New York , United States , Jack Khattar , Timothyc Dec , Jacka Khattar , Peter Vozzo , Securities Exchange , Exchange Commission , Supernus Pharmaceuticals , Supernus Pharmaceuticals Inc , Jefferies Healthcare Conference , Investor Relations , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President , Nc Stock Exchange , Press Release , Ystem Supn Us8684591089 ,

Supernus Pharmaceuticals : Corporate Overview May 2023

Supernus Pharmaceuticals

Corporate Overview

May 2023

© 2022 Supernus. | May 10, 2023 ....

Supernus Pharmaceuticals Inc , Exchange Commission , Securities Exchange , Safe Harbor Statement , Securities Exchange Act , All Rights , Supernus Pharmaceuticals , Nc Stock Exchange , Press Release , 022 Supn Us8684591089 ,

Supernus Pharmaceuticals : 2022 Annual Report

Dear Supernus Stockholder,

In 2022, we continued to execute on our long-term growth strategy focusing on successfully transitioning from our legacy and mature. | May 3, 2023 ....

Drug Administration , Dear Supernus Stockholder , New Drug Application , Novel Non Stimulant , Supernus Pharmaceuticals , Nc Stock Exchange , Press Release , Nd Supn Us8684591089 ,

Supernus Announces Repayment of Convertible Notes

ROCKVILLE, Md., April 03, 2023 Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system . | April 3, 2023 ....

Timothyc Dec , Peter Vozzo , Jacka Khattar , Securities Exchange , Supernus Pharmaceuticals , Exchange Commission , Supernus Pharmaceuticals Inc , Convertible Senior Notes , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President , Nc Stock Exchange , Press Release , Ystem Supn Us8684591089 ,

Supernus to Present at the 2022 Wells Fargo Healthcare Conference

ROCKVILLE, Md., Aug. 31, 2022 Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system . | August 31, 2022 ....

United States , Jack Khattar , Jacka Khattar , Timothyc Dec , Peter Vozzo , Exchange Commission , Securities Exchange , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Wells Fargo , Fargo Healthcare Conference , Encore Boston Harbor , Investor Relations , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President , Nc Stock Exchange , Press Release , Ystem Supn Us8684591089 ,